Novel mitochondria-targeted therapy AP39 limits mitochondrial dysregulation and diastolic dysfunction in 2D & 3D human models of diabetic cardiomyopathy
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Monash University, Melbourne (Australia)
6 More presentations in this session
Doctor S. Mallick (New Delhi, IN)
Doctor M. Mattingsdal (Gjettum, NO)
Doctor O. Iglesias Garcia (Pamplona, Navarra, ES)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation
